UPDATED Mar 19, 2024
Companies which may present a buying opportunity after a dip in share price.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SOM | €15.15 | -2.6% | -45.9% | €104.4m | €30.25 | PB3.5x | E50.4% | 5.3% | ||
TES | €0.093 | -2.1% | -41.7% | €56.0m | n/a | PB0.7x | E90.7% | 0% | ||
ESAU | €3.58 | -2.7% | -16.7% | €42.0m | €8.10 | PE7.2x | E18.7% | 2.8% | ||
NUS | €1.00 | -2.0% | -20.0% | €18.6m | €3.15 | PE13.6x | E38.7% | n/a | ||
SCK | €3.10 | -11.8% | -52.8% | €69.2m | €15.80 | PE3.2x | E4.3% | 9.0% | ||
LDO | €22.11 | 6.8% | 100.5% | €12.7b | €21.13 | PE19.3x | E13.5% | 1.3% | ||
TFIN | €0.37 | -2.8% | -5.1% | €115.5m | n/a | PE4.8x | E-46.6% | 0% | ||
ENY | €1.84 | -3.2% | -45.1% | €113.1m | €2.38 | PE6.5x | E-3.9% | n/a | ||
FDA | €0.37 | 2.8% | -73.8% | €2.6m | n/a | PB1.1x | n/a | 0% |